La Jolla, CA, United States of America

Frank Weiss

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Scripps Research Institute. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frank Weiss. Retrieved from https://idiyas.com/inventor/frank-weiss-n47v728a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 24.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Frank Weiss: Innovator in Coronavirus Treatment

Introduction

Frank Weiss is a notable inventor based in La Jolla, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of treatments for viral infections.

Latest Patents

Frank Weiss holds a patent for "Protease inhibitors for treatment of coronavirus infections." This patent includes compounds of Formula (I), their pharmaceutically acceptable salts, and their pharmaceutical compositions. The compounds are identified as potent inhibitors of the main protease (M) of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2). They are useful in treating or preventing COVID-19 in a subject.

Career Highlights

Frank Weiss is affiliated with The Scripps Research Institute, where he conducts his research and development work. His innovative approach to drug design has positioned him as a key figure in the fight against viral diseases.

Collaborations

Some of his notable coworkers include Arnab Kumar Chatterjee and Jian Jeffrey Chen. Their collaborative efforts contribute to advancing research in the field of virology.

Conclusion

Frank Weiss is a dedicated inventor whose work in developing protease inhibitors plays a crucial role in addressing coronavirus infections. His contributions are vital in the ongoing battle against COVID-19.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…